Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
F1000Research · 2025
DOI: 10.12688/f1000research.160416.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2025. Verfasst von Arman Yurisaldi Saleh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department Faculty of Medicine, Universitas Pembangunan Nasional (UPN) Veteran Jakarta, Jakarta, Special Capital Region of Jakarta, 12450, …. Hauptthemen laut MEDLINE: Ginkgo biloba, Bibliometrics, Nootropic Agents, Cognition. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 1417 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
1)
Introduction
Cognitive enhancers, or nootropics, are agents that aim to improve cognitive functions such as memory, attention, and executive processing. This bibliometric study investigates the scientific landscape surrounding Ginkgo biloba as a cognitive enhancer, using data retrieved from the Scopus database and analyzed via Biblioshiny and VOSviewer. This bibliometric study analyzes literature from Scopus to identify key trends, influential authors, and research gaps, providing guidance for future research. 2)
Methods
This study employs a literature review methodology to gather data from the Scopus database on Neuroaid, analyzing it using Biblioshiny and VOSviewer software. The focus was on Ginkgo Biloba as a niche-theme cognitive enhancer agent based on Scopus data, using both quantitative and qualitative analyses. 3) Results and discussion Ginkgo biloba, the ‘maidenhair tree’ from the order Ginkgoales, appeared 290 million years ago. Chinese and Japanese culture has been cultivated for thousands of years. This tree is valued for its resilience and therapeutic properties, often used in traditional medicine for respiratory and blood circulation issues. 4)
Conclusions
This bibliometric analysis reveals that Ginkgo biloba remains a focal point in cognitive enhancer research, with increasing scholarly attention over the past decade. Despite its historical and cultural significance, the literature shows fragmented research clusters and limited clinical consensus. The study highlights the need for standardized methodologies, stronger interdisciplinary collaboration, and more rigorous clinical trials to validate Ginkgo biloba’s cognitive benefits. These findings provide a roadmap for future research and underscore the importance of bridging traditional knowledge with modern scientific inquiry. This study was conducted in December 2024.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Department Faculty of Medicine, Universitas Pembangunan Nasional (UPN) Veteran Jakarta, Jakarta, Special Capital Region of Jakarta, 12450, Indonesia.
- Department of Public Health Sciences, Faculty of Medicine, Universitas Pembangunan Nasional (UPN) Veteran Jakarta, Jakarta, Special Capital Region of Jakarta, Indonesia.
- Family Medicine and Primary Care Department, Universitas Pelita Harapan, Tangerang, Banten, 15811, Indonesia.
ORCID-Profile: Arman Yurisaldi Saleh, Tirta Darmawan Susanto
Zitieren
APA
Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025). Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024. F1000Research. https://doi.org/10.12688/f1000research.160416.3
Vancouver
Saleh AY, Saputra DAY, Valentina R, Susanto TD. Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024. F1000Research. 2025. doi:10.12688/f1000research.160416.3
BibTeX
@article{Saleh2025,
author = {Saleh, Arman Yurisaldi and Saputra, Dwi Arwandi Yogi and Valentina, Riezky and Susanto, Tirta Darmawan},
title = {Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024},
journal = {F1000Research},
year = {2025},
doi = {10.12688/f1000research.160416.3}
}
EUVIMED